Everbliss contains Everolimus, a targeted anticancer medicine that belongs to the mTOR inhibitor class. Everolimus inhibits the mechanistic target of rapamycin (mTOR) pathway, which is involved in cell growth, proliferation, metabolism, and angiogenesis.

Everbliss may be used in the treatment of certain cancers and tumors, depending on the specific indication and treatment regimen. It is a prescription medicine and should be administered under the supervision of a qualified healthcare professional.

What is Everolimus?

Everolimus is an mTOR inhibitor and targeted antineoplastic agent. It works by blocking mTOR-mediated signaling pathways that contribute to tumor-cell growth and proliferation.

Depending on the formulation and approved indication, Everolimus is used in selected cases of advanced breast cancer, advanced renal cell carcinoma, and certain neuroendocrine tumors. It is also used for certain non-oncology conditions with specific formulations.

Benefits and Uses of Everbliss

Everbliss (Everolimus) may be prescribed for:

• Certain advanced breast cancers
• Selected cases of advanced renal cell carcinoma
• Certain neuroendocrine tumors
• Inhibition of mTOR signaling involved in tumor growth
• Reducing tumor-cell proliferation in appropriate treatment settings
• Combination treatment with other medicines when clinically indicated

The appropriate use depends on the patient’s diagnosis, disease stage, previous therapy, and treatment protocol.

Dosage Guidelines

The dosage of Everbliss varies according to the indication, formulation, combination treatment, and individual patient factors.

• Take Everbliss exactly as prescribed by the treating physician.
• Everolimus is commonly administered orally once daily in oncology treatment regimens.
• Take it consistently with respect to food, as food can affect Everolimus exposure.
• Swallow tablets whole with water unless the specific product instructions state otherwise.
• Do not alter the prescribed dose or discontinue treatment without medical advice.
• If a dose is missed, follow the instructions provided by the treating healthcare professional.

Regular monitoring may be required because Everolimus can cause clinically significant adverse effects and drug interactions.

Wholesale & Supply

Onco India International can support wholesale and bulk pharmaceutical supply of Everbliss (Everolimus) for eligible markets and procurement requirements.

Bulk supply may be suitable for:

• Pharmaceutical distributors
• Hospitals and healthcare institutions
• Oncology distributors
• International pharmaceutical buyers
• Licensed importers and exporters
• Healthcare procurement organizations

Packaging, documentation, minimum order quantities, and availability may vary according to market and regulatory requirements.

Buying Everolimus Online

When sourcing Everbliss or other Everolimus products, buyers should verify the product strength, dosage form, manufacturer, batch details, packaging, and applicable quality documentation.

Everolimus is a prescription medicine. Pharmaceutical products should be sourced through authorized and appropriately licensed suppliers and used under professional medical supervision.

Reviews

Individual experiences with Everolimus may differ based on the disease being treated, treatment regimen, dosage, and patient-specific factors.

For pharmaceutical procurement, important considerations include product quality, manufacturing standards, documentation, packaging integrity, and supply reliability rather than individual patient experiences alone.

Quality Assurance

Quality assurance is essential for oncology medicines such as Everolimus. Products should be manufactured, tested, packaged, and stored according to applicable pharmaceutical quality and regulatory standards.

Relevant product documentation, including available product specifications, batch information, certificates, and package inserts, can be requested where applicable.

Frequently Asked Questions

What is Everbliss used for?

Everbliss contains Everolimus and may be prescribed for certain advanced cancers, including selected breast cancer, renal cell carcinoma, and neuroendocrine tumor indications.

What type of medicine is Everolimus?

Everolimus is a targeted anticancer medicine classified as an mTOR inhibitor.

How does Everolimus work?

Everolimus inhibits the mTOR signaling pathway, which is involved in cellular growth, proliferation, metabolism, and other processes associated with tumor development.

Is Everbliss a prescription medicine?

Yes. Everolimus is a prescription medicine and should be used under the supervision of a qualified healthcare professional.

How is Everolimus administered?

Everolimus is generally administered orally. The dose and schedule depend on the specific indication and treatment regimen.

What are common side effects of Everolimus?

Possible adverse effects include stomatitis or mouth sores, rash, diarrhea, fatigue, infections, reduced blood-cell counts, increased blood glucose or lipids, and other reactions. Serious adverse effects are also possible.

Can Everolimus interact with other medicines?

Yes. Everolimus is metabolized primarily through CYP3A4 and is a P-glycoprotein substrate. Several medicines can therefore increase or decrease Everolimus exposure. The treating physician should review concomitant medicines.

Should Everolimus be used during pregnancy?

Everolimus may cause fetal harm. Pregnancy and contraception considerations should be discussed with the treating physician before and during treatment.

Conclusion

Everbliss (Everolimus) is a targeted mTOR inhibitor used in several oncology treatment settings. By inhibiting mTOR signaling, it can interfere with pathways involved in tumor-cell growth and proliferation.

Because Everolimus can cause significant adverse effects and interact with other medicines, it should be used according to an individualized treatment plan and under appropriate medical supervision.